Qian Yang

ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer

C. Morrissey, I. Garraway, E. Mostaghel, 2023, bioRxiv.

A druggable cascade links methionine metabolism to epigenomic reprogramming in squamous cell carcinoma.

Qifang Lei, H. Koeffler, Benjamin Ziman, 2024, Proceedings of the National Academy of Sciences of the United States of America.

ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer

C. Morrissey, I. Garraway, E. Mostaghel, 2024, Nucleic acids research.